Rationale and design of a multisite randomized clinical trial examining an integrated behavioral treatment for veterans with co-occurring chronic pain and opioid use disorder: The pain and opioids integrated treatment in veterans (POSITIVE) trial

Fayaz, 2016, Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies, BMJ Open, 6, 1, 10.1136/bmjopen-2015-010364 Dahlhamer, 2018, Prevalence of chronic pain and high-impact chronic pain among adults — United States, 2016, MMWR Morb. Mortal. Wkly Rep., 67, 1001, 10.15585/mmwr.mm6736a2 Breivik, 2006, Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment, Eur. J. Pain, 10, 287, 10.1016/j.ejpain.2005.06.009 Nicholas, 2019, The IASP classification of chronic pain for ICD-11, Pain., 160, 28, 10.1097/j.pain.0000000000001390 Ballantyne, 2010, Ethical issues in opioid prescribing for chronic pain, Pain., 148, 365, 10.1016/j.pain.2009.10.020 Bailey, 2015, Chronic noncancer pain and opioids : risks, benefits, and the public health debate, Prof. Psychol. Res. Pr., 46, 340, 10.1037/pro0000022 Centers for Disease Control and Prevention Volkow Scholl, 2019, Drug and opioid-involved overdose deaths — United States, 2013–2017, Morb. Mortal. Wkly Rep., 67, 1419 Birnbaum, 2011, Societal costs of prescription opioid abuse, dependence , and misuse in the United States, Pain Med., 12, 657, 10.1111/j.1526-4637.2011.01075.x O’Connor, 2013, Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations, Pain., 154, 2324, 10.1016/j.pain.2013.06.035 Smith, 2013, Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations, Pain., 154, 2287, 10.1016/j.pain.2013.05.053 Martell, 2007, Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction, Ann. Intern. Med., 146, 116, 10.7326/0003-4819-146-2-200701160-00006 Vowles, 2015, Rates of opioid misuse, abuse, and addiciton in chronic pain: a systematic review and data synthesis, Pain., 156, 569, 10.1097/01.j.pain.0000460357.01998.f1 Häuser, 2021, European* clinical practice recommendations on opioids for chronic noncancer pain – part 1: role of opioids in the management of chronic noncancer pain, Eur. J. Pain, 25, 949, 10.1002/ejp.1736 Wollschlaeger, 2017, Characteristics and treatment patterns of US commercially insured and Medicaid patients with opioid dependence or abuse, J. Opioid Manag., 13, 207, 10.5055/jom.2017.0389 Hser, 2017, Chronic pain among patients with opioid use disorder: results from electronic health records data, J. Subst. Abus. Treat., 77, 26, 10.1016/j.jsat.2017.03.006 Sandbrink, 2020, Opioid prescribing and opioid risk mitigation strategies in the veterans health administration, J. Gen. Intern. Med., 35, 927, 10.1007/s11606-020-06258-3 Clark, 2002, Chronic pain prevalence and analgesic prescribing in a general medical population, J. Pain Symptom Manag., 23, 131, 10.1016/S0885-3924(01)00396-7 Gironda, 2006, Pain among veterans of operations enduring freedom and Iraqi freedom, Pain Med., 7, 339, 10.1111/j.1526-4637.2006.00146.x Thomas, 2006, Pain in veterans of the Gulf War of 1991: a systematic review, BMC Musculoskelet. Disord., 7, 74, 10.1186/1471-2474-7-74 Helmer, 2009, Chronic widespread pain, mental health, and physical role function in OEF/OIF veterans, Pain Med., 10, 1174, 10.1111/j.1526-4637.2009.00723.x Kerns, 2003, Veterans’ reports of pain and associations with ratings of health, health-risk behaviors, affective distress, and use of the healthcare system, J. Rehabil. Res. Dev., 40, 371, 10.1682/JRRD.2003.09.0371 Morasco, 2010, Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain, Pain., 151, 625, 10.1016/j.pain.2010.08.002 Gellad, 2017, Addressing the opioid epidemic in the United States: lessons from the Department of Veterans Affairs, JAMA Intern. Med., 177, 611, 10.1001/jamainternmed.2017.0147 Department of Veterans Affairs. Opioid Prescribing Data, Accessed 27 January 2023. https://www.data.va.gov/stories/s/Department-of-Veterans-Affairs-Opioid-Prescribing-/4tx7-hu2d/. Reid, 2002, Use of opioid medications for chronic noncancer pain syndromes in primary care, J. Gen. Intern. Med., 17, 173, 10.1046/j.1525-1497.2002.10435.x Edlund, 2007, Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain, Pain., 129, 355, 10.1016/j.pain.2007.02.014 Chen, 2014, Buprenorphine–Naloxone Therapy in Pain Management, Anesthesiology., 120, 1262, 10.1097/ALN.0000000000000170 Lazaridou, 2020, Is buprenorphine effective for chronic pain? A systematic review and meta-analysis, Pain Med., 1 Avery, 2022 Amato, 2011, Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification, Cochrane Database Syst. Rev., 9 Griffin, 2016, Longitudinal association between pain severity and subsequent opioid use in prescription opioid dependent patients with chronic pain, Drug Alcohol Depend., 163, 216, 10.1016/j.drugalcdep.2016.04.023 Vowles, 2020, Integrated behavioral treatment for veterans with co-morbid chronic pain and hazardous opioid use: a randomized controlled pilot trial, J. Pain, 7-8, 798, 10.1016/j.jpain.2019.11.007 Chan, 2013, SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials, BMJ., 346, 10.1136/bmj.e7586 American Psychological Association, 2018 Bowen, 2014, Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders, JAMA Psychiat., 71, 547, 10.1001/jamapsychiatry.2013.4546 Grant, 2017, Mindfulness-based relapse prevention for substance use disorders: a systematic review and meta-analysis, J. Addict. Med., 11, 386, 10.1097/ADM.0000000000000338 Vowles Bowen, 2011 Watson, 2019, Pain neuroscience education for adults with chronic musculoskeletal pain: a mixed-methods systematic review and meta-analysis, J. Pain, 20, 1140.e1, 10.1016/j.jpain.2019.02.011 US Department of Veterans Affairs, Opioid Safety Initiative Toolkit, Accessed 27 January 2023. https://www.va.gov/painmanagement/opioid_safety_initiative_osi.asp. Luoma, 2007 Chawla, 2010, The mindfulness-based relapse prevention adherence and competence scale: development, interrater reliability, and validity, Psychother. Res., 20, 388, 10.1080/10503300903544257 Amtmann, 2010, Development of a PROMIS item bank to measure pain interference, Pain., 150, 173, 10.1016/j.pain.2010.04.025 Butler, 2007, Development and validation of the current opioid misuse measure, Pain., 130, 144, 10.1016/j.pain.2007.01.014 Chou, 2009, Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American pain society and American Academy of pain medicine clinical practice guideline, J. Pain, 10, 131, 10.1016/j.jpain.2008.10.009 Kroenke, 2001, The PHQ-9: validity of a brief depression severity measure, J. Gen. Intern. Med., 16, 606, 10.1046/j.1525-1497.2001.016009606.x Louzon, 2016, Does suicidal ideation as measured by the PHQ-9 predict suicide among VA patients?, Psychiatr. Serv., 67, 517, 10.1176/appi.ps.201500149 McCracken, 2002, A short version of the pain anxiety symptoms scale (PASS-20): preliminary development and validity, Pain Res. Manag., 7, 45, 10.1155/2002/517163 Vowles, 2004, Pain-related anxiety in the prediction of chronic low-back pain distress, J. Behav. Med., 27, 77, 10.1023/B:JOBM.0000013645.40613.42 Vowles, 2007, Evaluating outcomes in the interdisciplinary treatment of chronic pain: a guide for practicing clinicians, 203 Vlaeyen, 2012, Fear-avoidance model of chronic musculoskeletal pain: 12 years on, Pain., 153, 1144, 10.1016/j.pain.2011.12.009 Sobell, 1996 Del Boca, 2003, The validity of self-reports of alcohol consumption: state of the science and challenges for research, Addiction., 98, 1, 10.1046/j.1359-6357.2003.00586.x Pedersen, 2012, Concurrent validity of an online version of the timeline Followback assessment, Psychol. Addict. Behav., 26, 672, 10.1037/a0027945 Sobell, 1996, The reliability of the alcohol timeline Followback when administered by telephone and by computer, Drug Alcohol Depend., 42, 49, 10.1016/0376-8716(96)01263-X Witkiewitz, 2015, Recommendations for the design and analysis of treatment trials for alcohol use disorders, Alcohol. Clin. Exp. Res., 39, 1557, 10.1111/acer.12800 McNeely, 2016, Performance of the tobacco, alcohol, prescription medication, and other substance use (TAPS) tool for substance use screening in primary care patients, Ann. Intern. Med., 165, 690, 10.7326/M16-0317 McCracken, 2004, Acceptance of chronic pain: component analysis and a revised assessment method, Pain., 107, 159, 10.1016/j.pain.2003.10.012 Pielech, 2016, Preliminary evaluation of the values tracker: a two-item measure of engagement in valued activities in those with chronic pain, Behav. Modif., 40, 239, 10.1177/0145445515616911 Flannery, 1999, Psychometric properties of the Penn alcohol craving scale, Alcohol. Clin. Exp. Res., 23, 1289, 10.1111/j.1530-0277.1999.tb04349.x Witkiewitz, 2013, Mindfulness-based relapse prevention for substance craving, Addict. Behav., 38, 1563, 10.1016/j.addbeh.2012.04.001 McCracken, 2005, Acceptance-based treatment for persons with complex, long standing chronic pain: a preliminary analysis of treatment outcome in comparison to a waiting phase, Behav. Res. Ther., 43, 1335, 10.1016/j.brat.2004.10.003 Vowles, 2011, Acceptance and values-based action in chronic pain: a three-year follow-up analysis of treatment effectiveness and process, Behav. Res. Ther., 49, 748, 10.1016/j.brat.2011.08.002 Vowles, 2014, Acceptance and commitment therapy for chronic pain: evidence of mediation and clinically significant change following an abbreviated interdisciplinary program of rehabilitation, J. Pain, 15, 101, 10.1016/j.jpain.2013.10.002 Vowles, 2007, Processes of change in treatment for chronic pain: the contributions of pain, acceptance, and catastrophizing, Eur. J. Pain, 11, 779, 10.1016/j.ejpain.2006.12.007 Witkiewitz, 2010, Depression, craving, and substance use following a randomized trial of mindfulness-based relapse prevention, J. Consult. Clin. Psychol., 78, 362, 10.1037/a0019172 Fritz, 2007, Required sample size to detect the mediated effect, Psychol. Sci., 18, 233, 10.1111/j.1467-9280.2007.01882.x MacKinnon, 2002, A comparison of methods to test mediation and other intervening variable effects, Psychol. Methods, 7, 83, 10.1037/1082-989X.7.1.83 MacKinnon, 2008 Schafer, 2002, Missing data: our view of the state of the art, Psychol. Methods, 7, 147, 10.1037/1082-989X.7.2.147 Edwards, 2022, Changes in pain during buprenorphine maintenance treatment among patients with opioid use disorder and chronic pain, J. Consult. Clin. Psychol., 90, 314, 10.1037/ccp0000692 Witkiewitz, 2018, Alcohol and opioid use, co-use, and chronic pain in the context of the opioid epidemic: a critical review, Alcohol. Clin. Exp. Res., 42, 478, 10.1111/acer.13594